Edition:
United States

Advaxis Inc (ADXS.OQ)

ADXS.OQ on NASDAQ Stock Exchange Global Select Market

0.36USD
22 Feb 2019
Change (% chg)

$-0.02 (-6.07%)
Prev Close
$0.39
Open
$0.38
Day's High
$0.40
Day's Low
$0.36
Volume
64,625
Avg. Vol
138,817
52-wk High
$2.24
52-wk Low
$0.18

Chart for

About

Advaxis, Inc. is a clinical-stage biotechnology company focused on the discovery, development and commercialization of Listeria monocytogenes (Lm)-Listeriolysin O (LLO) cancer immunotherapies. These immunotherapies are based on a platform technology that utilizes live attenuated Lm bioengineered to secrete antigen/adjuvant... (more)

Overall

Beta: 2.03
Market Cap(Mil.): $187.67
Shares Outstanding(Mil.): 41.07
Dividend: --
Yield (%): --

Financials

  ADXS.OQ Industry Sector
P/E (TTM): -- 69.44 33.70
EPS (TTM): -2.29 -- --
ROI: -105.74 8.92 14.45
ROE: -116.33 10.08 15.96

Earnings vs. Estimates